Systematic review Domestic animal endocrinology · 2026 Metabolic and endocrine modulation of the gut-adipose tissue axis via pro-, pre-, and postbiotics in overweight dogs: A systematic review. Southwell M, Faraco M, Ruíz MJ, et al. Akkermansia muciniphilaBifidobacterium animalisBifidobacterium breveEnterococcus faecium PubMed ↗
Randomized trial Cancer prevention research · 2026 Weight Loss and Omega-3 Supplementation Modulate the Microbiome in Women with Increased Breast Cancer Risk. Cook KL, Giles ED, Sekela JJ, et al. Alistipes putredinisPhocaeicola vulgatus PubMed ↗
Review Medicina · 2026 Gut Microbiota in Metabolic Syndrome: Differences in Microbial Signatures and Clinical Profiles. Scarlata GGM, Belančić A, Scarpellini E, et al. Akkermansia muciniphila PubMed ↗
Randomized trial Nutrients · 2026 Autoprobiotic Supplements Attenuate Obesity and Improve Gut Microbiota, Carbohydrate, and Lipid Metabolism in Patients with Metabolic Syndrome: A Pilot Trial. Ermolenko E, Sitkin S, Alferova L, et al. Bacteroides fragilisEnterococcus faecium PubMed ↗
Observational Journal of applied microbiology · 2026 Multi-omics analysis identify novel microbiome-metabolome signatures associated with obesity. Tian B, Liu Y, Su KJ, et al. Bacteroides fragilisVeillonella dispar PubMed ↗
Randomized trial Clinical nutrition ESPEN · 2026 Effect of continuous energy restriction combined with probiotic supplementation on parameters related to homeostatic and hedonic systems of food intake in adult men living with obesity: Data from a randomized, parallel, double-blind, placebo-controlled clinical trial. Lucin GA, Marques CG, Magalhães ACO, et al. Bifidobacterium animalis PubMed ↗
Observational Journal of applied microbiology · 2026 Gut species Porphyromonas asaccharolytica and Bacteroides fragilis are associated with whole body fat percentage. Tian B, Liu Y, Su KJ, et al. Bacteroides fragilis PubMed ↗
Randomized trial Cancer reports · 2026 Dance and Dietary Intervention Improves Metabolic Health, Fitness, and Quality of Life With Modest Gut Microbiota Shifts in Breast Cancer Patients With Obesity: A Pilot RCT. Nechalová L, Penesová A, Hric I, et al. Faecalibacterium prausnitziiRuminococcus bromii PubMed ↗
Randomized trial Obesity · 2026 Effect of Sevelamer and B. longum on Insulin Sensitivity in Participants With Obesity: A Randomized Clinical Trial. Baeuerle E, Semwal MK, Nie J, et al. Bifidobacterium longum PubMed ↗
Randomized trial Nature medicine · 2026 Pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people with overweight and obesity: a controlled randomized trial. Mount S, Canfora EE, Jocken JW, et al. Akkermansia muciniphila PubMed ↗
Review JAMA · 2026 Obesity and Cancer: A Translational Science Review. Shen S, Brown KA, Green AK, et al. Akkermansia muciniphila PubMed ↗
Randomized trial Food research international · 2026 Timing matters in type 2 diabetes: Early high-Fiber nutrition enhances glycemic control and reshapes gut microbiota. Wang L, Liang C, Yu J, et al. Akkermansia muciniphila PubMed ↗
Review Letters in applied microbiology · 2026 Anti-obesity effects of probiotics beyond BMI: a critical review of human clinical trials. Athapaththu HAD, Dey G Bifidobacterium breveLactobacillus gasseri PubMed ↗
Review Microbial pathogenesis · 2026 Understanding gut microbiota dysbiosis as a plausible link between obstructive sleep apnea (OSA), viral infections, and lifestyle diseases. Karthik S S, Jadhav P, Paul A, et al. Akkermansia muciniphilaFaecalibacterium prausnitzii PubMed ↗
Observational Gut microbes · 2026 Parasutterella excrementihominis is associated with attenuated metabolic improvements during obesity therapy in humans. Liu S, Schlicht K, Beckmann A, et al. Parasutterella excrementihominis PubMed ↗
Observational Journal of gastroenterology · 2026 Escherichia coli as a gut microbial marker of obesity and its reduction following bariatric treatment. Hayashi T, Iida N, Yasuda K, et al. Escherichia coli PubMed ↗
Observational mSystems · 2026 Gut microbiome signatures associated with depression and obesity. Mora-Martínez C, Molina-Mendoza G, Cenit MC, et al. Faecalibacterium prausnitzii PubMed ↗
Randomized trial Journal of the American Nutrition Association · 2026 Supplementation With Lactococcus lactis LMG 27352: Lack of Beneficial Effects on Cardiometabolic Risk in Obese Patients Without Concomitant Dietary Intervention-A Randomized, Triple-Blind, Placebo-Controlled Clinical Trial. Morais MA, Sousa BA, Lima de Oiveira JP, et al. Lactococcus lactis PubMed ↗
Randomized trial Diabetes care · 2026 Prediction of Weight Loss and Regain Based on Multiomic and Phenotypic Features: Results From a Calorie-Restricted Feeding Trial. Li L, Li R, Qiu Z, et al. Bifidobacterium adolescentisRuminococcus callidus PubMed ↗
Randomized trial Clinical nutrition · 2025 Effects of a novel synbiotic intervention on abdominal visceral fat reductions and gut microbiota in overweight and obese adults: A randomized, double-blind, placebo-controlled trial. Li N, Zhu Z, Wu S, et al. Bifidobacterium animalis PubMed ↗
Randomized trial Probiotics and antimicrobial proteins · 2025 Bifidobacterium Breve BBr60 Improves Obesity Via the Gut Microbiota-Short-Chain Fatty Acid-IL-27/GLP-1 Axis: Evidence from a Randomized, Double-Blind, Placebo-Controlled Trial. Gao D, Dong Y, Jia Z, et al. Bifidobacterium breve PubMed ↗
Observational BMC microbiology · 2025 High alcohol-producing Escherichia coli causes obesity and steatotic liver disease in a non-alcoholic cohort -a preclinical study. Singh A, Singh DN, Singh AN, et al. Escherichia coli PubMed ↗
Observational Nature communications · 2025 Prevotella copri promotes white adipose browning and ameliorates adiposity. Liu S, Li H, Li R, et al. Segatella copri PubMed ↗
Systematic review Endocrinologia, diabetes y nutricion · 2025 Taxonomic and functional characteristics of the gut microbiota in obesity: A systematic review. Díaz Perdigones CM, Hinojosa Nogueira D, Rodríguez Muñoz A, et al. Faecalibacterium prausnitzii PubMed ↗
Review American journal of physiology. Cell physiology · 2025 From gut to blood: barrier dysfunction as a driver of systemic low-grade inflammation in cardiometabolic disease. Yang-Jensen SK, Nägele NS, Jensen BAH Akkermansia muciniphila PubMed ↗
Observational Nutrients · 2025 Gut Dysbiosis and Plasma Trimethylamine Oxide Are Associated with Subclinical Coronary Atherosclerosis in Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease. Islam K, Kongsomboonchoke P, Chayanupatkul M, et al. Mediterraneibacter gnavus PubMed ↗
Randomized trial Journal of agricultural and food chemistry · 2025 Metabolite Biomarkers Linking a High-Fiber Rye Intervention with Cardiometabolic Risk Factors: The RyeWeight Study. Unión Caballero A, Meroño T, Åberg S, et al. [Ruminococcus] torques PubMed ↗
Review Nutrients · 2025 Integrating Precision Medicine and Digital Health in Personalized Weight Management: The Central Role of Nutrition. Liu X, Xu M, Wang H, et al. Akkermansia muciniphila PubMed ↗
Systematic review Diabetes, obesity & metabolism · 2025 Interaction between dietary omega-3 polyunsaturated fatty acids, obesity and gut microbiota in preclinical models: A systematic review of randomized controlled trials. Cao B, Sun Y, Lam C, et al. Akkermansia muciniphila PubMed ↗
Review Expert review of endocrinology & metabolism · 2025 Gut microbiota alterations and their role in the pathophysiology of obesity following bariatric surgery. Voermans B, Gerdes V, Nieuwdorp M Akkermansia muciniphila PubMed ↗
Randomized trial Clinical nutrition ESPEN · 2025 Comparing the effects of yogurt containing Akkermansia muciniphilia postbiotic with yogurt containing Lactobacillus rhamnosus postbiotic on body composition, biochemical indices, appetite, and depression scores in overweight or obese adults: A randomized, double-blind, controlled clinical trial. Aalipanah E, Askarpour M, Eskandari MH, et al. Akkermansia muciniphila PubMed ↗
Observational Diabetes · 2025 Metabolic Dysfunction Associated With Alterations in Gut Microbiota in Adolescents With Obesity. Granato A, Xie QY, Wong A, et al. Escherichia coli PubMed ↗
Randomized trial Nutricion hospitalaria · 2025 Effects of probiotic supplementation on blood lipids ın hypercholesterolemic obese patients: a randomized, double-blind, placebo-controlled pilot trial. Bulut S, Kabaran S Bifidobacterium animalisBifidobacterium longumEnterococcus faecium PubMed ↗
Observational Nutrition, metabolism, and cardiovascular diseases · 2025 Links between gut microbiota with specific serum metabolite groups in pregnant women with overweight or obesity. Lotankar M, Houttu N, Benchraka C, et al. Alistipes finegoldiiBacteroides cellulosilyticusEnterocloster bolteaeMediterraneibacter gnavus PubMed ↗
Systematic review Indian journal of gastroenterology · 2025 Impact of bariatric surgery on gut microbiota in obese patients: A systematic review. Mohammadzadeh N, Razavi S, Shahriari M, et al. Akkermansia muciniphila PubMed ↗
Review Journal of bacteriology · 2025 Unraveling the gut microbiota's role in obesity: key metabolites, microbial species, and therapeutic insights. Iqbal M, Yu Q, Tang J, et al. Akkermansia muciniphilaCollinsella aerofaciens PubMed ↗
Review Letters in applied microbiology · 2025 Exploring the anti-obesity effects of Lactobacillus in C57BL/6 mice: mechanisms, interventions, and future directions. Lim SYM, Chong EJ, Mah WY, et al. Lactobacillus gasseri PubMed ↗
Randomized trial Journal of health, population, and nutrition · 2025 The effect of probiotic-fortified kefir on depression, appetite, oxidative stress, and inflammatory parameters in Iranian overweight and obese elderly: a randomized, double-blind, placebo-controlled clinical trial. Noori M, Shateri Z, Babajafari S, et al. Bifidobacterium longum PubMed ↗
Observational Journal of cachexia, sarcopenia and muscle · 2025 Distinct Gut Microbiota Profiles in Normal Weight Obesity and Their Association With Cardiometabolic Diseases: Results From Two Independent Cohort Studies. Wang W, Wang F, Li Y, et al. [Ruminococcus] torquesMediterraneibacter gnavus PubMed ↗
Randomized trial Cell metabolism · 2025 Akkermansia muciniphila supplementation in patients with overweight/obese type 2 diabetes: Efficacy depends on its baseline levels in the gut. Zhang Y, Liu R, Chen Y, et al. Akkermansia muciniphila PubMed ↗